LCID
Lucid Group, Inc.
LCID has the edge over MBC overall, supported by stronger fundamentals and stronger modeled upside.
MBC
MasterBrand, Inc.
MBC has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MBC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
MBC's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MBC PE Valuation
MBC has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MBC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect MBC's revenue to grow, but its earnings and profitability to decline.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over MBC on earnings, with more consistent year-over-year improvement.
MBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.87 | -238% |
| Q2 2026 | -$0.68 | -196% |
| Q1 2026 | -$0.01 | -101% |
| Q4 2025 | $0.21 | -78% |
| Q3 2025 | $0.63 | -45% |
| Q2 2025 | $0.71 | -49% |
| Q1 2025 | $0.77 | -46% |
| Q4 2024 | $0.96 | -31% |
MBC has swung to a loss: it lost $0.87 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MBC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1B | +48% |
| Q2 2026 | $815.2M | +12% |
| Q1 2026 | $618M | -6.4% |
| Q4 2025 | $644.6M | -3.5% |
| Q3 2025 | $698.9M | -2.7% |
| Q2 2025 | $730.9M | +8% |
| Q1 2025 | $660.3M | +3.5% |
| Q4 2024 | $667.7M | -1.4% |
MBC's revenue has picked up after two years of holding roughly level: $1B last quarter, up 48% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1% | -5 points |
| Q2 2026 | -3.4% | -13 points |
| Q1 2026 | -3% | -8.6 points |
| Q4 2025 | -4.2% | -9.8 points |
| Q3 2025 | 6% | -2 points |
| Q2 2025 | 9.2% | -2.3 points |
| Q1 2025 | 5.6% | -4.2 points |
| Q4 2024 | 5.6% | -3.4 points |
MBC has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $61.2M | +55% |
| Q2 2026 | $128.6M | +93% |
| Q1 2026 | -$146.2M | -$105M |
| Q4 2025 | $52.5M | -24% |
| Q3 2025 | $39.5M | -39% |
| Q2 2025 | $66.7M | +0.9% |
| Q1 2025 | -$41.2M | -452% |
| Q4 2024 | $68.8M | +107% |
MBC has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over MBC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +32% | +49.9M shares |
| 1 year | +57% | +74M shares |
| 3 years | +56% | +73.2M shares |
| 5 years | +59% | +75.5M shares |
MBC has 204M diluted shares, up 57% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $6.7M |
| Q1 2025 | $11.4M |
| Q4 2024 | — |
MBC hasn't bought back shares in the past year.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 12.7x | High |
| Q2 2026 | 13.4x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.0x | Elevated |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 3.2x | Elevated |
| Q4 2024 | 2.8x | Moderate |
MBC's net debt is about 13 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.3 | Neutral |
| Stochastic | 16.4 | Oversold |
MBC's weekly RSI is 35 (neutral) and its Stochastic is 16 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MBC PE vs Consumer Cyclical Sector
| Metric | MBC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MBC has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.89 | 10% below |
| 20 week MA | $7.91 | 22% below |
| 50 week MA | $9.12 | 32% below |
| 100 week MA | $10.9 | 43% below |
| 200 week MA | $12.4 | 50% below |
MBC is in a downtrend: it's below all five of its weekly moving averages, and 50% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $10.0 | $7.58 | -24% |
| 2023 | $7.58 | $14.9 | +96% |
| 2024 | $14.9 | $14.4 | -2.8% |
| 2025 | $14.4 | $11.3 | -22% |
| 2026 YTD | $11.3 | $6.19 | -45% |
MBC has the edge over LCID on returns for 2026, with the stronger performance.